Glomerular changes and alterations of zonula occludens-1 in the kidneys of Plasmodium falciparum malaria patients
© Wichapoon et al.; licensee BioMed Central Ltd. 2014
Received: 24 January 2014
Accepted: 29 April 2014
Published: 9 May 2014
The process of cytoadhesion in Plasmodium falciparum malaria infection causes signaling processes that lead to structural and functional changes at the cellular level. Histopathological changes of acute kidney injury (AKI) in P. falciparum malaria often involve glomerular proliferation, thickening of the glomerular basement membrane, acute tubular necrosis, and interstitial inflammation. Focusing on the glomeruli, this study aimed to investigate glomerular and tight junction-associated protein- zonula occludens-1 (ZO-1) changes in P. falciparum malaria patients.
Kidney tissues were grouped into P. falciparum with AKI (Cr ≥ 265 μmol/L or 3 mg/dl), P. falciparum without AKI (Cr < 265 μmol/L), and normal kidney tissues (control group). Glomerular cells and the glomerular area were quantified and compared in three experimental groups. The tight junction was investigated immunohistochemically using tight junction-associated protein, ZO-1, protein marker. A further immunofluorescence study was performed in an endothelial cell (EC)-parasitized red blood cell (PRBC) co-culture system, to evaluate the tight junction protein.
Glomerular cell proliferation was significant in P. falciparum with AKI (Cr ≥ 265 μmol/L). By contrast, the glomerular area decreased significantly. ZO-1 expression was significantly decreased in the AKI group compared with normal kidneys, and in kidney tissues without AKI (p < 0.05). This was further confirmed by the depletion in ZO-1 localization in ECs co-cultured with PRBCs.
In P. falciparum malaria with AKI, the decrease in glomerular area, despite glomerular cell proliferation, could be due to the collapse of cellular structures secondary to damaged tight junction-associated protein, ZO-1.
KeywordsZonula occludens-1 ZO-1 Tight junction Kidney Glomeruli Plasmodium falciparum Acute kidney injury AKI
Malaria infection caused by Plasmodium falciparum is the world’s most widespread infection. Among its severe manifestations, acute kidney injury (AKI) is an important complication, which can cause mortality of up to 45% . The overall incidence of AKI has been reported as between 1-4.8% in endemic areas, and 25-30% in non-immune patients . Malarial complications are possibly caused by the interaction of the parasite with the host, resulting in mechanical, immunologic, and humoral responses. Responses to eliminate malaria parasites may also injure host tissues . The precise mechanism of AKI in P. falciparum malaria is not fully understood. Several hypotheses proposed for the pathogenesis of AKI in malaria include mechanical obstruction by parasitized red blood cells (PRBCs), exaggerated host immune response mediated through cytokines, reactive oxygen and nitrogen species, immune complex deposition, hypovolaemia, and disturbances in the renal microcirculation . Changes in the glomeruli often include glomerular cell proliferation, basement membrane thickening, presence of PRBCs and protein deposition within the mesangium, endothelial cell wall, and Bowman’s capsule . The process of cytoadhesion of PRBCs to the vascular endothelial cells (ECs) of different host organs, along with rosette formation, is considered the most important mechanism of severe P. falciparum malaria . ECs located in the capillary loop of the glomeruli provide target adhesion sites for PRBCs. This leads to the disruption of the EC barrier and eventually affects vascular permeability. Tight junctions are located apical to the EC surface and composed of multiple transmembrane, scaffolding, and signaling proteins. There are at least three different types of transmembrane proteins within tight junctions: occludin, claudins, and junctional adhesion molecule (JAM) . Zonula occludens-1 (ZO-1) proteins are found associated with the cytoplasmic surfaces of tight junctions [7, 8]. They are in contact with the extracellular tight junction membrane proteins and provide a link between the integral membrane proteins and the filamentous cytoskeleton. In addition to the evaluation of glomerular changes in the kidney of P. falciparum patients, this study focused on structural alterations to the junction-associated protein, ZO-1, in P. falciparum malaria.
Kidney tissues from fatal P. falciparum cases were classified into P. falciparum with acute kidney injury (AKI) (creatinine, (Cr) ≥ 265 μmol/L or 3 mg/dl), and P. falciparum without AKI (Cr < 265 μmol/L), based on Cr level before death. Control kidney tissues were obtained from stored specimens collected from accident fatalities with no kidney pathology, showing normal glomeruli, basement membrane, and tubules. The use of specimens and the research protocol were approved by the Ethics Committee of the Faculty of Tropical Medicine, Mahidol University (MUTM 2011-018-01, MUTM 2011-018-02). The pertinent clinical data documented from patient’s charts included sex, age, days of fever, admission parasite count, last parasite count, admission blood urea nitrogen (BUN) level, last BUN level, admission serum Cr, last serum Cr, day of hospitalization, and other complications.
All tissue were fixed in 10% buffered formalin for at least 24-48 hrs, then were subjected to standard histological processing for paraffin-embedded section. Kidney tissues were sectioned at 4 μm in thickness for histopathological and immunohistochemical studies. To evaluate the glomerular changes, kidney tissues were stained with Mayer’s haematoxylin and eosin (H&E). All cells within the glomeruli (mesangial cells, endothelial cells (ECs) and podocytes) were quantified based on morphology, by randomization from 30 glomeruli in a patient under 400x magnification. Mesangial cells are found inside the mesangium. ECs are localized inside the glomerular capillaries, in close contact with the capillary wall. Cells located outside, but in direct contact with the capillary wall, are considered podocytes . In addition, the glomerular area was measured and analysed by the computer software program, “Image J analysis” , at a magnification of 100x. The slides were read blind to the clinical details of the patients by two persons (PV and BW).
Immunohistochemical study of ZO-1
The expression of ZO-1 was detected by avidin-biotin peroxidase complex technique (Vector Laboratories, Inc., Burlingame, CA) according to the manufacturer’s protocol. Before immunohistochemical staining, the tissue sections were heated at 56.5°C, then deparaffinized and hydrated through xylene and graded alcohol series. All tissue sections were blocked for endogenous peroxidase activity and incubated for 30 mins in 3% H2O2 diluted in distilled water. The slides were then washed 4 times with Tris-buffer saline (TBS), at pH 7.4, for 5 mins. To induced epitope retrieval, the tissue sections were heated with Tris-HCl buffer (pH 9.0) by microwave oven at 800 W for 20 mins. After cooling to room temperature (RT), the slides were washed in TBS and were blocked with diluted normal goat serum for 30 mins to reduce the non-specific background. Then, the sections were incubated with primary antibody; rabbit polyclonal anti-ZO-1 (Invitrogen Corporation, Frederick, MD) (1:50 dilution) in blocking solution and incubated overnight at 4°C. The following day, the sections were washed 4 times in TBS, and incubated with diluted biotinylated secondary antibody; biotinylated goat anti-rabbit immunoglobulin (Vector Laboratories, Inc., Burlingame, CA) for 30 mins at RT to detect polyclonal antibody, and reacted with avidin-biotin complex (ABC) method conjugated with horseradish peroxidase (HRP) (Dako Laboratories, Inc., Glostrup, Denmark) for 30 mins. After washing, the peroxidase reaction was visualized with 0.05% 3,3’ diaminobenzidine (DAB) and 0.01% H2O2 for 10 mins, resulting in the formation of a brown reaction product at the antigen sites. Subsequently, the sections were counterstained with haematoxylin for 1 min. The slides were rinsed in running tap water for 10 mins, dehydrated, cleared, mounted with a cover slip and evaluated under a light microscope.
Evaluation of immunohistochemistry staining
The proportions of immunopositive cells stained for ZO-1 were assessed. The expression of ZO-1 is specific for tight junction-associated protein  and stained brown in the glomeruli. Each slide was observed on ten different representative microscopic fields for immunopositive cells stained for the target marker. Consequently, the percentage of positive cells in each field was calculated compared with the number of total cells, and the average number of positive cells. Staining intensity was graded on a scale of 0 to 3, according to semi-quantitative assessment, as follows: 0 = no detectable staining, 1 = weakly positive, 2 = moderately positive, and 3 = strongly positive. The total score (TS) was calculated from the product of the percentage of immunopositive cells (%) and intensity (I) [Total score (TS) = percentage of positive cells (%) × intensity (I)], according to previous studies [12, 13].
Immunofluorescence study of tight junction (ZO-1) in ECs co-cultured with PRBCs
Preparation of ECs
To further investigate alterations in tight junction, an EC-malaria parasite model was used in the study. Human umbilical vein endothelial cells (HUVEC) were cultured from passage 4-6 (a gift from Prof. Steve Ward, Liverpool School of Tropical Medicine, UK). When HUVEC reached 80-90% confluence (in T25 flask), cells were trypsinized, seeded on 35 mm diameter gelatin-coated coverslip (Bioptechs, Butler, PA) and placed in a 40 mm diameter Petri dish. Approximately 500 μl of cell suspension were gently loaded onto the coated coverslips at a seeding density of 15,000-20,000 cells/cm2. Cells were allowed to settle for 1 hr at 37°C, 5% CO2, in a humidified incubator. The EC medium was then removed and 3 ml of pre-warmed fresh medium were added. Cells were then further cultured on the coverslip until they reached 80-90% confluence and were suitable for co-culture with PRBCs.
Preparation of PRBCs
Plasmodium falciparum strain ITG (a gift from Prof. Alister Craig, Liverpool School of Tropical Medicine, UK) was cultured to 5-8% parasitaemia (trophozoite or schizont stages).
Co-culture of ECs with PRBCs
The concentrated parasites were re-suspended in 1% fetal calf serum (FCS) in medium 199 to a parasitaemia of 50% in 1% haematocrit. EC medium was removed from the attached ECs (80-90% confluence) and the cells were gently washed once with 1X phosphate buffered saline solution (PBS). Parasite suspension (3 ml) was then added to the HUVEC monolayer. The co-culture dishes were gently agitated either clockwise or counter clockwise every 10-15 mins for 1 hr to allow more cell-to-cell contact, and co-cultured for 24 hr at 37°C, 5% CO2, in a humidified incubator. Control groups consisted of ECs grown on media alone and ECs cultured with red blood cell (RBC) suspension prepared to a haematocrit of 1% (medium 199 and 1% FCS).
Immunofluorescence staining of ZO-1
After 24 hrs of co-culture, PRBCs, RBCs and the media were gently removed from the HUVEC monolayer and washed gently with 1X PBS. The remaining attached EC monolayer was fixed with fresh 4% paraformadehyde in PBS for 15 mins, then rinsed with EC media. The ECs were gently washed 2 times with 1X PBS and permeabilized for 5 mins in RT with 2% Triton X-100 in 1X PBS. Cells were labeled with Anti-ZO-1 tight junction protein (Zymed Laboratories Inc. Laboratories, South San Francisco, CA) (1: 100 dilution) at 37°C, incubated for 1 hr, then washed 3 times with 1X PBS. An AlexaFluor®-conjugated goat anti-rabbit polyclonal IgG (Jackson Immunoresearch, West Grove, PA) (1: 400 dilution) was used as the secondary antibody. The ECs were incubated for 45 mins at 37°C, then the cells were washed 3 times with 2% Triton X-100 in 1X PBS. Nuclei were stained with DAPI (Invitrogen, Carlsbad, CA) (1 μg/ml; 5000X) in 1X PBS for 2 mins then washed once in 1X PBS. A small drop of mounting solution with anti-fade solution (Vector Laboratories, Burlingame, CA) was added to each slide and covered gently with a coverslip to prevent air bubbles. The cells were left for 15-30 mins at RT and sealed with nail polish.
Evaluation of ZO-1
Tight junction-associated protein, ZO-1, was considered altered when ZO-1 expression was depleted or the cell junction lacked continuity. ECs with damaged cell junctions were counted randomly in 300-450 cells and expressed as percentages.
Data were analysed using descriptive statistics. All quantitative data were presented as mean ± standard error of mean (SEM). Normality of distribution was tested by Kolmogorov-Smirnov test. Comparison of difference in the mean, SEM, was calculated by one-way analysis of variance (ANOVA). The Pearson’s correlation test was used to estimate the strength and direction of the correlation between the expression of ZO-1 and the clinical data. Statistical analysis was performed using SPSS version 14.0 software (SPSS, Chicago, IL). Statistical significance was set at p-value ≤ 0.05.
Clinical and laboratory data of malaria patients
Demographic and clinical data of the malaria patients
non-AKI (n = 10)
AKI (n = 10)
27.9 ± 5.5
27.3 ± 4.1
Days of fever
14.99 ± 0.57
19.88 ± 1.44
Parasitaemia (on admission) (/μl)
379,813 ± 183,575
285,666 ± 90,400
Parasitaemia (last) (/μl)
32,897 ± 31,971
54,121 ± 51,804
BUN (on admission) (mmol/L)
14.46 ± 3.87
41.99 ± 4.54*
BUN (last) (mmol/L)
13.66 ± 2.54
32.53 ± 5.40*
Cr (on admission) (μmol/L)
124.74 ± 11.83
532.17 ± 70.73*
Cr (last) (μmol/L)
168.84 ± 30.62
432.44 ± 75.91*
Glomerular changes in P. falciparum malaria
Evaluation of glomerular cells
Glomerular cells in the kidney of control, non-AKI (Cr < 265 μmol/L), and AKI (Cr ≥ 265 μmol/L), groups
Glomerular cell types in a glomerulus
Control (n = 10)
non-AKI (n = 10)
AKI (n = 10)
11.91 ± 0.22
12.63 ± 0.28
19.28 ± 1.67*’**
66.24 ± 4.40
81.23 ± 2.49
88.13 ± 4.21*’**
12.04 ± 0.98
14.99 ± 0.57
19.88 ± 1.44*’**
Total glomerular cells
30.06 ± 5.72
36.02 ± 7.16
42.43 ± 7.24*’**
Evaluation of glomerular area
Expression of ZO-1
Evaluation of ZO-1 using ECs-PRBCs model
In the AKI (Cr ≥ 265 μmol/L) group, histopathological changes in the glomeruli included proliferation of glomerular cells, protein deposition in the glomerular space, and decreased in the glomerular area, aside from the presence of parasitized red blood cells (PRBCs) inside the capillary lumen and marked congestion. Tubular cell changes showed cloudy swelling, a certain degree of tubular degeneration, and tubular necrosis. Chronic interstitial inflammation, consisting mainly of lymphocytes, was an important feature found in AKI. The thickening of the glomerular basement membrane was observed occasionally, which is similar to previous reports [2, 4]. Protein deposition localized in the glomerular space could be immune complex deposits containing IgG, C3, and malarial antigens . Glomerular cells, namely mesangial cells, ECs and podocytes, in the AKI were quantified based on morphology. The results showed a significant increase in glomerular cells in AKI kidneys with P. falciparum malaria compared with normal kidneys and non-AKI, consistent with previous studies [2, 14–16]. In addition, the present study demonstrated a significant positive correlation between glomerular cells (mesangial cells, ECs, and podocytes) and serum Cr level, indicating that high levels of serum Cr affects glomerular cell proliferation in the kidneys of malaria patients. Proliferation of the glomerular cells is also a prominent feature of glomerular disease, including IgA nephropathy, membrano-proliferative glomerulonephritis, lupus nephritis, and diabetic nephropathy . Glomerular cell proliferation may be due to the immune response secondary to cytokine release during malaria infection, by both host immune cells and malaria parasites. However, the glomerular area does not correlate with glomerular cell proliferation. The glomerular area was significantly reduced in AKI compared with non-AKI and normal kidneys, in contrast with the finding of glomerular cell proliferation. This can possibly be explained by glomerular constriction as a consequence of the damaged tight junction-associated protein, ZO-1 in AKI. The loss of tight junction-associated protein was demonstrated by the decrease in ZO-1 expression in the immunohistochemical study, and the damaged cell junction was illustrated by the immunofluorescence study. The alteration of ZO-1 may induce collapse of protein structures of EC cellular junctions. Subsequently, this causes glomerular cell contraction, which contributes to the decrease in glomerular area in malarial AKI. In addition, a negative correlation was seen between glomerular area and serum Cr level in AKI cases.
Tight-junction permeability may be regulated directly through modification of tight-junction proteins, or indirectly through effects on the cytoskeleton. Associated protein tight junction ZO-1 is a scaffold protein that provides the structural basis at the cytoplasmic surface of intercellular junctions, and localizes specifically at tight junctions [18, 19]. ZO-1 is the most widely studied tight junction protein and plays an important role in stabilizing the tight junction complex structure  and signaling transduction . In addition, ZO-1 is localized between foot processes in the glomerulus . The ZO-1 protein possibly connects the slit diaphragm, indirectly or directly, to the cytoskeleton of a cell . Changes in ZO-1 distribution and disruption of tight junction proteins, have been reported in hypoxia  and in oxygen glucose deprivation , resulting in increased EC permeability . At the molecular level, ZO-1 changes can enhance permeability via tyrosine phosphorylation .
In malaria, ZO-1 reportedly plays an important role in the blood-brain barrier in cerebral malaria . Destruction of EC-junction proteins--ZO-1, occludin and vinculin--in cerebral malaria has been reported . An in vitro study of EC-PRBC co-culture showed decreased expression of tight junction RNAs from cerebral malaria patients. The study concluded that PRBCs can alter tight junction protein expression in ECs at the site of sequestration, and can influence disease severity . The present study demonstrated that protein tight junction (ZO-1) was weakly detected in glomeruli and tubules. An additional study, using anti-ZO-1 to localize tight junction-associated protein, confirmed ZO-1 alteration and damage of the EC tight junction in ECs co-cultured with PRBCs. In the glomeruli, ZO-1 is localized in the capillary EC junction and between the foot processes. The structural alteration of the cell junction can increase cell permeability, leading to fluid and protein leakage. These changes cause further damage when coupled with hypovolaemia in malarial AKI. Further study of other junction and associated membrane proteins will help resolve the subcellular structural alteration responsible for permeability changes in severe malaria.
Malarial AKI involves glomerular cell proliferation, despite reduced glomerular area. This study of tight junction-associated protein revealed a damaged tight junction structure (ZO-1) in severe P. falciparum malaria, associated with AKI. The ZO-1 damage in malarial AKI could contribute to the collapse of junction structures, thereby reducing glomerular area, which further increases cellular permeability. The finding suggests that AKI could contribute to ZO-1 damage and provide an insight into the pathogenesis of AKI in P. falciparum malaria infection.
This study was supported by the National Research Council of Thailand (NRCT) (contract number: 2554-127). BW acknowledged the Outbound Exchange Student Programme 2013 from the Faculty of Tropical Medicine, Mahidol University. We thank all staff at the Department of Tropical Pathology, Faculty of Tropical Medicine, Mahidol University, Thailand for their support throughout this study.
- Liano F, Pascual J: Epidemiology of acute renal failure: a prospective, multicenter, community-based study. Madrid Acute Renal Failure Study Group. Kidney Int. 1996, 50: 811-818. 10.1038/ki.1996.380.View ArticlePubMedGoogle Scholar
- Barsoum RS: Malarial acute renal failure. J Am Soc Nephrol. 2000, 11: 2147-2154.PubMedGoogle Scholar
- Das BS: Renal failure in malaria. J Vector Borne Dis. 2008, 45: 83-97.PubMedGoogle Scholar
- Mishra SK, Das BS: Malaria and acute kidney injury. Semin Nephrol. 2008, 28: 395-408. 10.1016/j.semnephrol.2008.04.007.View ArticlePubMedGoogle Scholar
- Pongponratn E, Riganti M, Punpoowong B, Aikawa M: Microvascular sequestration of parasitized erythrocytes in human falciparum malaria: a pathological study. Am J Trop Med Hyg. 1991, 44: 168-175.PubMedGoogle Scholar
- Harhaj NS, Antonetti DA: Regulation of tight junctions and loss of barrier function in pathophysiology. Int J Biochem Cell Biol. 2004, 36: 1206-1237. 10.1016/j.biocel.2003.08.007.View ArticlePubMedGoogle Scholar
- Beatch M, Jesaitis LA, Gallin WJ, Goodenough DA, Stevenson BR: The tight junction protein ZO-2 contains three PDZ (PSD-95/Discs-Large/ZO-1) domains and an alternatively spliced region. J Biol Chem. 1996, 271: 25723-25726. 10.1074/jbc.271.42.25723.View ArticlePubMedGoogle Scholar
- Balda MS, Gonzalez-Mariscal L, Matter K, Cereijido M, Anderson JM: Assembly of the tight junction: the role of diacylglycerol. J Cell Biol. 1993, 123: 293-302. 10.1083/jcb.123.2.293.View ArticlePubMedGoogle Scholar
- Baak JP, Wehner H: A multivariate morphometric analysis of the glomeruli in the normal and pathologically changed human kidney. Virchows Arch A Pathol Anat Histopathol. 1983, 399: 105-114.View ArticlePubMedGoogle Scholar
- Rangan GK, Tesch GH: Quantification of renal pathology by image analysis. Nephrology (Carlton). 2007, 12: 553-558. 10.1111/j.1440-1797.2007.00855.x.View ArticleGoogle Scholar
- Rincon-Choles H, Vasylyeva TL, Pergola PE, Bhandari B, Bhandari K, Zhang JH, Wang W, Gorin Y, Barnes JL, Abboud HE: ZO-1 expression and phosphorylation in diabetic nephropathy. Diabetes. 2006, 55: 894-900. 10.2337/diabetes.55.04.06.db05-0355.View ArticlePubMedGoogle Scholar
- Konstantinidou AE, Givalos N, Gakiopoulou H, Korkolopoulou P, Kotsiakis X, Boviatsis E, Agrogiannis G, Mahera H, Patsouris E: Caspase-3 immunohistochemical expression is a marker of apoptosis, increased grade and early recurrence in intracranial meningiomas. Apoptosis. 2007, 12: 695-705. 10.1007/s10495-006-0001-4.View ArticlePubMedGoogle Scholar
- Punsawad C, Maneerat Y, Chaisri U, Nantavisai K, Viriyavejakul P: Nuclear factor kappa B modulates apoptosis in the brain endothelial cells and intravascular leukocytes of fatal cerebral malaria. Malar J. 2013, 12: 260-10.1186/1475-2875-12-260.PubMed CentralView ArticlePubMedGoogle Scholar
- Eiam-Ong S, Sitprija V: Falciparum malaria and the kidney: a model of inflammation. Am J Kidney Dis. 1998, 32: 361-375. 10.1053/ajkd.1998.v32.pm9740151.View ArticlePubMedGoogle Scholar
- Boonpucknavig V, Sitprija V: Renal disease in acute Plasmodium falciparum infection in man. Kidney Int. 1979, 16: 44-52. 10.1038/ki.1979.101.View ArticlePubMedGoogle Scholar
- Eiam-Ong S: Malarial nephropathy. Semin Nephrol. 2003, 23: 21-33. 10.1053/snep.2003.50002.View ArticlePubMedGoogle Scholar
- Kurogi Y: Mesangial cell proliferation inhibitors for the treatment of proliferative glomerular disease. Med Res Rev. 2003, 23: 15-31. 10.1002/med.10028.View ArticlePubMedGoogle Scholar
- Stevenson BR, Siliciano JD, Mooseker MS, Goodenough DA: Identification of ZO-1: a high molecular weight polypeptide associated with the tight junction (zonula occludens) in a variety of epithelia. J Cell Biol. 1986, 103: 755-766. 10.1083/jcb.103.3.755.View ArticlePubMedGoogle Scholar
- Anderson JM, Stevenson BR, Jesaitis LA, Goodenough DA, Mooseker MS: Characterization of ZO-1, a protein component of the tight junction from mouse liver and Madin-Darby canine kidney cells. J Cell Biol. 1988, 106: 1141-1149. 10.1083/jcb.106.4.1141.View ArticlePubMedGoogle Scholar
- An P, Xue YX: Effects of preconditioning on tight junction and cell adhesion of cerebral endothelial cells. Brain Res. 2009, 1272: 81-88.View ArticlePubMedGoogle Scholar
- Huber JD, Egleton RD, Davis TP: Molecular physiology and pathophysiology of tight junctions in the blood–brain barrier. Trends Neurosci. 2001, 24: 719-725. 10.1016/S0166-2236(00)02004-X.View ArticlePubMedGoogle Scholar
- Kurihara H, Anderson JM, Farquhar MG: Diversity among tight junctions in rat kidney: glomerular slit diaphragms and endothelial junctions express only one isoform of the tight junction protein ZO-1. Proc Natl Acad Sci U S A. 1992, 89: 7075-7079. 10.1073/pnas.89.15.7075.PubMed CentralView ArticlePubMedGoogle Scholar
- Ruotsalainen V, Ljungberg P, Wartiovaara J, Lenkkeri U, Kestila M, Jalanko H, Holmberg C, Tryggvason K: Nephrin is specifically located at the slit diaphragm of glomerular podocytes. Proc Natl Acad Sci U S A. 1999, 96: 7962-7967. 10.1073/pnas.96.14.7962.PubMed CentralView ArticlePubMedGoogle Scholar
- Fischer S, Wiesnet M, Marti HH, Renz D, Schaper W: Simultaneous activation of several second messengers in hypoxia-induced hyperpermeability of brain derived endothelial cells. J Cell Physiol. 2004, 198: 359-369. 10.1002/jcp.10417.View ArticlePubMedGoogle Scholar
- Mark KS, Davis TP: Cerebral microvascular changes in permeability and tight junctions induced by hypoxia-reoxygenation. Am J Physiol Heart Circ Physiol. 2002, 282: H1485-H1494.PubMed CentralView ArticlePubMedGoogle Scholar
- Adams S, Brown H, Turner G: Breaking down the blood–brain barrier: signaling a path to cerebral malaria?. Trends Parasitol. 2002, 18: 360-366. 10.1016/S1471-4922(02)02353-X.View ArticlePubMedGoogle Scholar
- Brown H, Hien TT, Day N, Mai NT, Chuong LV, Chau TT, Loc PP, Phu NH, Bethell D, Farrar J, Gatter K, White N, Turner G: Evidence of blood–brain barrier dysfunction in human cerebral malaria. Neuropathol Appl Neurobiol. 1999, 25: 331-340. 10.1046/j.1365-2990.1999.00188.x.View ArticlePubMedGoogle Scholar
- Susomboon P, Maneerat Y, Dekumyoy P, Kalambaheti T, Iwagami M, Komaki-Yasuda K, Kawazu S, Tangpukdee N, Looareesuwan S, Kano S: Down-regulation of tight junction mRNAs in human endothelial cells co-cultured with Plasmodium falciparum-infected erythrocytes. Parasitol Int. 2006, 55: 107-112. 10.1016/j.parint.2005.11.054.View ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.